Navigation Links
Smokers More Likely to Develop Dementia

Tobacco users had a 50% higher risk for Alzheimer's, Dutch study finds

TUESDAY, Sept. 4 (HealthDay News) -- Current smokers are 50 percent more likely to develop Alzheimer's disease or dementia than people who don't smoke or who gave up smoking, a Dutch report says.

Researchers announced these results after analyzing seven years of data from almost 7,000 people over age 55.

Over the course of the study, 706 people developed dementia. People who were smokers during the study were 50 percent more likely to develop dementia than people who had never smoked or were former smokers, according to the researchers, who published their findings in the Sept. 4 issue of Neurology.

"Smoking increases the risk of cerebrovascular disease, which is also tied to dementia," study author Dr. Monique Breteler, of Erasmus Medical Center in Rotterdam, the Netherlands, said in a prepared statement. "Another mechanism could be through oxidative stress, which can damage cells in the blood vessels and lead to hardening of the arteries. Smokers experience greater oxidative stress than nonsmokers, and increased oxidative stress is also seen in Alzheimer's disease."

Oxidative stress occurs when there are too many waste products from chemical reactions in the body. Dietary antioxidants can fight those waste products, known as free radicals, but Breteler said that smokers are also known to have fewer antioxidants in their diets than nonsmokers.

The researchers also studied the way that smoking affects the risk of Alzheimer's disease for people who carry the related gene. They found that smoking did not increase the risk for those with the gene for Alzheimer's disease, but it did increase the risk for people without the gene. Current smokers without the gene were 70 percent more likely to develop Alzheimer's disease than nonsmokers or former smokers without the gene.

More information

To learn more about smoking cessation, visit the American Cancer Society Guide to Quitting Smoking.

-- Madeline Vann

SOURCE: American Academy of Neurology, news release, Sept. 3, 2007

Copyright©2007 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Half of worlds children are passive smokers - damning disclosure from WHO
2. Glaxo launches pills to help smokers quit in 7-12 weeks
3. Poor diet among smokers
4. Pregnant smokers could harm their child
5. Creating A Greater Awareness Among Smokers
6. B-Carotene Increases Oral Cancer Risk In Smokers
7. Smokers Cloud Has A Silver Lining?
8. Smokers children likely to develop caries
9. Drinkers and smokers are at risk
10. A new method to help smokers quit
11. Poor diet among smokers
Post Your Comments:
(Date:12/1/2015)... Viejo, CA (PRWEB) , ... December 01, 2015 , ... ... length of footage, and with full control over customization, the possibilities are truly endless, ... frame rate, position randomization, overlay depth position, vertical flip, horizontal flip, depth of field ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... receiving the 2015 HSJ Acute Sector Innovation Award on November 18th. This prestigious ... care experience, and propose exciting enhancements to the medical landscape. , The UCLH ...
(Date:11/30/2015)... Cary, NC (PRWEB) , ... November 30, 2015 ... ... Dominique Dawes, Amanda Beard and Brooke Bennett are collaborating with brands across various ... , These four influential figures make up an elite group of Gold Medal ...
(Date:11/30/2015)... , ... December 01, 2015 , ... ... Christina Colon as a 2015-2016 inductee into its VIP Woman of the ... NAPW is the nation’s leading networking organization exclusively for professional women, boasting 850,000 ...
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... ... programs of the19th Bi-National Convention of the Federation of Philippine American Chambers of ... in Las Vegas, Nevada. , 1Heart Caregiver Services, as an active delegate ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... --  MabVax Therapeutics Holdings, Inc . (OTCQB: MBVX), a ... an Investigational New Drug Application (IND) with the U.S. ... fully human antibody product HuMab 5B1 as a therapeutic ... the Phase I clinical trial early in 2016. ... planned Phase I trial will evaluate the safety, tolerability ...
(Date:12/1/2015)... 2015  Booth #3506 – Claymount is featuring its full ... of the Radiological Society of North America ... Based in the Netherlands , Claymount is ... (NYSE: VAR ) and is one of the world,s ... state automatic exposure control systems for controlling dose during medical ...
(Date:12/1/2015)... , Dec. 1, 2015  Lexicon Pharmaceuticals, ... that top-line data from its TELECAST Phase ... in treating carcinoid syndrome in cancer patients ... clinical benefit observed in its pivotal TELESTAR ... a companion to TELESTAR primarily to provide ...
Breaking Medicine Technology: